BioPortfolio - Eukarion Incorporated - Profile
View the current Eukarion Incorporated Page on BioPortfolio.com ... Eukarion's protein modification program is directed at blocking the function of ...
http://www.bioportfolio.com/biocorporate/3953-Eukarion+Incor...
|
Partial volume rat lung irradiation: the protective/mitigating ...
BACKGROUND AND PURPOSE: The purpose of the current study was to elucidate the protective/mitigating effects of a SOD-catalase mimetic, Eukarion-189 ...
http://www.ncbi.nlm.nih.gov/pubmed/16675053...
|
BioPortfolio - BioPortfolio - Eukarion Incorporated
BioPortfolio - Eukarion Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/3953/www.eu...
|
News: Proteome Systems Announces Deal Worth $5 Million With 10 ...
7 May 2007 ... Dr. Fleming, Chairman and CEO of Minerva Healthcare added, "We have closely watched the development of the Eukarion compounds for almost a ...
http://www.genengnews.com/news/bnitem.aspx?name=16982273...
|
Buck Institute - First Successful Use of Drugs to Extend Lifespan ...
The Buck Institute and Eukarion, Inc. will continue to work together to further ... Eukarion, Inc. is a privately held biopharmaceutical company located in ...
http://www.buckinstitute.org/site/index.php?option=com_conte...
|
BioPortfolio - Biocorporate Search
Eukarion's protein modification program is directed at blocking the function of intracellular disease-associated targets using modified Lipoclonal® ...
http://www.bioportfolio.com/biocorporate/BioCorporate_Direct...
|
Buck Institute - Lifespan Extension and Prevention of Neurological ...
The SCSs are proprietary compounds developed by Eukarion that mimic the naturally ... Eukarion, Inc., a privately held biopharmaceutical company located
in ...
http://www.buckinstitute.org/site/index.php?option=com_conte...
|
Chronic antioxidant enzyme mimetic treatment diffe...[J Appl ...
This study utilized a superoxide dismutase/catalase mimetic (Eukarion-189) to evaluate the impact of a change in redox environment on age-related HSP70 ...
http://www.ncbi.nlm.nih.gov/pubmed/16254069?dopt=Abstract...
|
City (ZipCode), Organization PI Name Grant Number Amount Awarded ...
TOTAL AWARDS: $ 49569 BEDFORD (01730): EUKARION, INC. ... SYNTHETIC SOD/CATALASE MIMICS FOR STROKE BEDFORD (01730): EUKARION, INC. ...
http://report.nih.gov/award/state/fy1998.massachu.txt...
|
Proteome Systems Ltd. Strengthens Focus on Diagnostics and Exits ...
Simply put, the Eukarion portfolio no longer fits with our corporate development strategy,” said Jenny Harry, Chief Executive Officer of Proteome Systems. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=107601...
|
